375 related articles for article (PubMed ID: 27217147)
1. Exome sequencing for bipolar disorder points to roles of de novo loss-of-function and protein-altering mutations.
Kataoka M; Matoba N; Sawada T; Kazuno AA; Ishiwata M; Fujii K; Matsuo K; Takata A; Kato T
Mol Psychiatry; 2016 Jul; 21(7):885-93. PubMed ID: 27217147
[TBL] [Abstract][Full Text] [Related]
2. Exome Sequencing of Familial Bipolar Disorder.
Goes FS; Pirooznia M; Parla JS; Kramer M; Ghiban E; Mavruk S; Chen YC; Monson ET; Willour VL; Karchin R; Flickinger M; Locke AE; Levy SE; Scott LJ; Boehnke M; Stahl E; Moran JL; Hultman CM; Landén M; Purcell SM; Sklar P; Zandi PP; McCombie WR; Potash JB
JAMA Psychiatry; 2016 Jun; 73(6):590-7. PubMed ID: 27120077
[TBL] [Abstract][Full Text] [Related]
3. Functional and behavioral effects of de novo mutations in calcium-related genes in patients with bipolar disorder.
Nakamura T; Nakajima K; Kobayashi Y; Itohara S; Kasahara T; Tsuboi T; Kato T
Hum Mol Genet; 2021 Sep; 30(19):1851-1862. PubMed ID: 34100076
[TBL] [Abstract][Full Text] [Related]
4. De novo variation in bipolar disorder.
Goes FS; Pirooznia M; Tehan M; Zandi PP; McGrath J; Wolyniec P; Nestadt G; Pulver AE
Mol Psychiatry; 2021 Aug; 26(8):4127-4136. PubMed ID: 31776463
[TBL] [Abstract][Full Text] [Related]
5. Leveraging blood serotonin as an endophenotype to identify de novo and rare variants involved in autism.
Chen R; Davis LK; Guter S; Wei Q; Jacob S; Potter MH; Cox NJ; Cook EH; Sutcliffe JS; Li B
Mol Autism; 2017; 8():14. PubMed ID: 28344757
[TBL] [Abstract][Full Text] [Related]
6. Systematic analysis of exonic germline and postzygotic de novo mutations in bipolar disorder.
Nishioka M; Kazuno AA; Nakamura T; Sakai N; Hayama T; Fujii K; Matsuo K; Komori A; Ishiwata M; Watanabe Y; Oka T; Matoba N; Kataoka M; Alkanaq AN; Hamanaka K; Tsuboi T; Sengoku T; Ogata K; Iwata N; Ikeda M; Matsumoto N; Kato T; Takata A
Nat Commun; 2021 Jun; 12(1):3750. PubMed ID: 34145229
[TBL] [Abstract][Full Text] [Related]
7. Whole genome/exome sequencing in mood and psychotic disorders.
Kato T
Psychiatry Clin Neurosci; 2015 Feb; 69(2):65-76. PubMed ID: 25319632
[TBL] [Abstract][Full Text] [Related]
8. De novo mutations identified by exome sequencing implicate rare missense variants in SLC6A1 in schizophrenia.
Rees E; Han J; Morgan J; Carrera N; Escott-Price V; Pocklington AJ; Duffield M; Hall LS; Legge SE; Pardiñas AF; Richards AL; Roth J; Lezheiko T; Kondratyev N; Kaleda V; Golimbet V; Parellada M; González-Peñas J; Arango C; ; Gawlik M; Kirov G; Walters JTR; Holmans P; O'Donovan MC; Owen MJ
Nat Neurosci; 2020 Feb; 23(2):179-184. PubMed ID: 31932766
[TBL] [Abstract][Full Text] [Related]
9. Identification of candidate genes involved in the etiology of sporadic Tourette syndrome by exome sequencing.
Eriguchi Y; Kuwabara H; Inai A; Kawakubo Y; Nishimura F; Kakiuchi C; Tochigi M; Ohashi J; Aoki N; Kato K; Ishiura H; Mitsui J; Tsuji S; Doi K; Yoshimura J; Morishita S; Shimada T; Furukawa M; Umekage T; Sasaki T; Kasai K; KanoMD PhD Y
Am J Med Genet B Neuropsychiatr Genet; 2017 Oct; 174(7):712-723. PubMed ID: 28608572
[TBL] [Abstract][Full Text] [Related]
10. De novo CNVs in bipolar affective disorder and schizophrenia.
Georgieva L; Rees E; Moran JL; Chambert KD; Milanova V; Craddock N; Purcell S; Sklar P; McCarroll S; Holmans P; O'Donovan MC; Owen MJ; Kirov G
Hum Mol Genet; 2014 Dec; 23(24):6677-83. PubMed ID: 25055870
[TBL] [Abstract][Full Text] [Related]
11. Genes with de novo mutations are shared by four neuropsychiatric disorders discovered from NPdenovo database.
Li J; Cai T; Jiang Y; Chen H; He X; Chen C; Li X; Shao Q; Ran X; Li Z; Xia K; Liu C; Sun ZS; Wu J
Mol Psychiatry; 2016 Feb; 21(2):290-7. PubMed ID: 25849321
[TBL] [Abstract][Full Text] [Related]
12. Refining the role of de novo protein-truncating variants in neurodevelopmental disorders by using population reference samples.
Kosmicki JA; Samocha KE; Howrigan DP; Sanders SJ; Slowikowski K; Lek M; Karczewski KJ; Cutler DJ; Devlin B; Roeder K; Buxbaum JD; Neale BM; MacArthur DG; Wall DP; Robinson EB; Daly MJ
Nat Genet; 2017 Apr; 49(4):504-510. PubMed ID: 28191890
[TBL] [Abstract][Full Text] [Related]
13. De novo mutations revealed by whole-exome sequencing are strongly associated with autism.
Sanders SJ; Murtha MT; Gupta AR; Murdoch JD; Raubeson MJ; Willsey AJ; Ercan-Sencicek AG; DiLullo NM; Parikshak NN; Stein JL; Walker MF; Ober GT; Teran NA; Song Y; El-Fishawy P; Murtha RC; Choi M; Overton JD; Bjornson RD; Carriero NJ; Meyer KA; Bilguvar K; Mane SM; Sestan N; Lifton RP; Günel M; Roeder K; Geschwind DH; Devlin B; State MW
Nature; 2012 Apr; 485(7397):237-41. PubMed ID: 22495306
[TBL] [Abstract][Full Text] [Related]
14. Rare deleterious mutations are associated with disease in bipolar disorder families.
Rao AR; Yourshaw M; Christensen B; Nelson SF; Kerner B
Mol Psychiatry; 2017 Jul; 22(7):1009-1014. PubMed ID: 27725659
[TBL] [Abstract][Full Text] [Related]
15. De Novo Synonymous Mutations in Regulatory Elements Contribute to the Genetic Etiology of Autism and Schizophrenia.
Takata A; Ionita-Laza I; Gogos JA; Xu B; Karayiorgou M
Neuron; 2016 Mar; 89(5):940-7. PubMed ID: 26938441
[TBL] [Abstract][Full Text] [Related]
16. Deep exome sequencing identifies enrichment of deleterious mosaic variants in neurodevelopmental disorder genes and mitochondrial tRNA regions in bipolar disorder.
Nishioka M; Takayama J; Sakai N; Kazuno AA; Ishiwata M; Ueda J; Hayama T; Fujii K; Someya T; Kuriyama S; Tamiya G; Takata A; Kato T
Mol Psychiatry; 2023 Oct; 28(10):4294-4306. PubMed ID: 37248276
[TBL] [Abstract][Full Text] [Related]
17. Loss-of-function variants in schizophrenia risk and SETD1A as a candidate susceptibility gene.
Takata A; Xu B; Ionita-Laza I; Roos JL; Gogos JA; Karayiorgou M
Neuron; 2014 May; 82(4):773-80. PubMed ID: 24853937
[TBL] [Abstract][Full Text] [Related]
18. Family-based exome-sequencing approach identifies rare susceptibility variants for lithium-responsive bipolar disorder.
Cruceanu C; Ambalavanan A; Spiegelman D; Gauthier J; Lafrenière RG; Dion PA; Alda M; Turecki G; Rouleau GA
Genome; 2013 Oct; 56(10):634-40. PubMed ID: 24237345
[TBL] [Abstract][Full Text] [Related]
19. Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study.
Rauch A; Wieczorek D; Graf E; Wieland T; Endele S; Schwarzmayr T; Albrecht B; Bartholdi D; Beygo J; Di Donato N; Dufke A; Cremer K; Hempel M; Horn D; Hoyer J; Joset P; Röpke A; Moog U; Riess A; Thiel CT; Tzschach A; Wiesener A; Wohlleber E; Zweier C; Ekici AB; Zink AM; Rump A; Meisinger C; Grallert H; Sticht H; Schenck A; Engels H; Rappold G; Schröck E; Wieacker P; Riess O; Meitinger T; Reis A; Strom TM
Lancet; 2012 Nov; 380(9854):1674-82. PubMed ID: 23020937
[TBL] [Abstract][Full Text] [Related]
20. Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations.
O'Roak BJ; Deriziotis P; Lee C; Vives L; Schwartz JJ; Girirajan S; Karakoc E; Mackenzie AP; Ng SB; Baker C; Rieder MJ; Nickerson DA; Bernier R; Fisher SE; Shendure J; Eichler EE
Nat Genet; 2011 Jun; 43(6):585-9. PubMed ID: 21572417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
